Given the alerted activation status of circulating CD14+ monocytes and their ability to accumulate in the affected organs in SSc, we believe that further research should focus on finding even more targeted therapies, which may invert the activation status of monocytes in the circulation. Here, CD14 is linked to systemic sclerosis.